 Dae Won Park
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 8 | 2018 | 490 | 2.200 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2022 | 545 | 1.640 |
Why?
| | Biomimetic Materials | 4 | 2017 | 72 | 1.450 |
Why?
| | Tissue Scaffolds | 5 | 2019 | 211 | 1.350 |
Why?
| | Retinal Ganglion Cells | 2 | 2025 | 110 | 1.350 |
Why?
| | Gels | 3 | 2020 | 80 | 1.060 |
Why?
| | Delayed-Action Preparations | 3 | 2018 | 181 | 1.030 |
Why?
| | Hydrogels | 6 | 2025 | 678 | 0.970 |
Why?
| | Optic Nerve Injuries | 1 | 2025 | 9 | 0.950 |
Why?
| | Axons | 2 | 2025 | 198 | 0.940 |
Why?
| | Chelating Agents | 1 | 2025 | 75 | 0.920 |
Why?
| | Nerve Growth Factors | 1 | 2025 | 79 | 0.920 |
Why?
| | Polyurethanes | 2 | 2015 | 38 | 0.870 |
Why?
| | Tissue Engineering | 5 | 2025 | 423 | 0.830 |
Why?
| | Zinc | 1 | 2025 | 297 | 0.750 |
Why?
| | Temperature | 3 | 2025 | 679 | 0.720 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 179 | 0.720 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1809 | 0.710 |
Why?
| | Acrylamides | 2 | 2018 | 57 | 0.680 |
Why?
| | Materials Testing | 5 | 2025 | 356 | 0.680 |
Why?
| | Biocompatible Materials | 3 | 2025 | 425 | 0.680 |
Why?
| | Drug Delivery Systems | 2 | 2014 | 365 | 0.670 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 24 | 0.590 |
Why?
| | Sulfones | 1 | 2018 | 110 | 0.560 |
Why?
| | Neurites | 2 | 2016 | 48 | 0.550 |
Why?
| | Nerve Regeneration | 2 | 2016 | 59 | 0.540 |
Why?
| | Spina Bifida Cystica | 1 | 2017 | 2 | 0.540 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2018 | 179 | 0.510 |
Why?
| | Amniotic Fluid | 1 | 2017 | 96 | 0.500 |
Why?
| | Myocardium | 2 | 2019 | 1002 | 0.500 |
Why?
| | Air Filters | 1 | 2015 | 3 | 0.490 |
Why?
| | Myocardial Infarction | 2 | 2022 | 1046 | 0.480 |
Why?
| | Acrylic Resins | 2 | 2018 | 46 | 0.480 |
Why?
| | Meningomyelocele | 3 | 2021 | 59 | 0.470 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 261 | 0.460 |
Why?
| | Stroke Volume | 1 | 2018 | 612 | 0.460 |
Why?
| | Biodegradable Plastics | 1 | 2014 | 3 | 0.450 |
Why?
| | Triamcinolone Acetonide | 1 | 2014 | 28 | 0.450 |
Why?
| | Micelles | 1 | 2014 | 39 | 0.450 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 64 | 0.450 |
Why?
| | Nanoparticles | 2 | 2025 | 481 | 0.430 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 446 | 0.430 |
Why?
| | Animals | 20 | 2025 | 36940 | 0.430 |
Why?
| | Neurogenesis | 1 | 2015 | 149 | 0.410 |
Why?
| | Neural Stem Cells | 1 | 2015 | 156 | 0.410 |
Why?
| | Heparin | 1 | 2014 | 261 | 0.400 |
Why?
| | Heart Ventricles | 1 | 2018 | 788 | 0.400 |
Why?
| | Motor Neurons | 1 | 2015 | 234 | 0.400 |
Why?
| | Silicon Dioxide | 1 | 2013 | 115 | 0.390 |
Why?
| | Wet Macular Degeneration | 1 | 2013 | 56 | 0.380 |
Why?
| | Rats | 7 | 2025 | 5647 | 0.370 |
Why?
| | Nanotubes, Carbon | 2 | 2025 | 47 | 0.360 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 229 | 0.350 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 804 | 0.350 |
Why?
| | Anti-Inflammatory Agents | 1 | 2014 | 496 | 0.340 |
Why?
| | Contrast Media | 1 | 2013 | 467 | 0.340 |
Why?
| | Cattle | 3 | 2017 | 984 | 0.280 |
Why?
| | Mice | 9 | 2025 | 17787 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 4 | 2025 | 2486 | 0.280 |
Why?
| | Peptides | 1 | 2013 | 985 | 0.280 |
Why?
| | Myocytes, Cardiac | 4 | 2025 | 526 | 0.270 |
Why?
| | Cell Survival | 2 | 2025 | 1120 | 0.270 |
Why?
| | Antiviral Agents | 1 | 2013 | 744 | 0.260 |
Why?
| | Biomimetics | 2 | 2016 | 44 | 0.250 |
Why?
| | Nerve Crush | 1 | 2025 | 9 | 0.240 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2025 | 12 | 0.240 |
Why?
| | Picolinic Acids | 1 | 2025 | 9 | 0.240 |
Why?
| | Laminin | 2 | 2016 | 72 | 0.230 |
Why?
| | Gelatin | 2 | 2022 | 52 | 0.220 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 131 | 0.220 |
Why?
| | Neuroprotective Agents | 1 | 2025 | 131 | 0.220 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2014 | 201 | 0.210 |
Why?
| | Nanofibers | 2 | 2013 | 21 | 0.210 |
Why?
| | Lidocaine | 1 | 2022 | 42 | 0.190 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2129 | 0.190 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2253 | 0.180 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.170 |
Why?
| | Tissue Adhesives | 1 | 2020 | 19 | 0.160 |
Why?
| | Urea | 1 | 2020 | 81 | 0.160 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 93 | 0.160 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 107 | 0.150 |
Why?
| | Fetoscopy | 1 | 2018 | 30 | 0.150 |
Why?
| | Particle Size | 2 | 2025 | 394 | 0.150 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 157 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 83 | 0.140 |
Why?
| | Gold | 1 | 2019 | 118 | 0.140 |
Why?
| | Surgical Wound | 1 | 2018 | 23 | 0.140 |
Why?
| | Alginates | 1 | 2018 | 46 | 0.140 |
Why?
| | Organophosphorus Compounds | 1 | 2018 | 78 | 0.140 |
Why?
| | Biomedical Engineering | 1 | 2017 | 27 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 303 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4295 | 0.130 |
Why?
| | Fetus | 2 | 2021 | 806 | 0.130 |
Why?
| | Neural Tube Defects | 1 | 2017 | 64 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2013 | 2475 | 0.120 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 129 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 84 | 0.120 |
Why?
| | Sulfonic Acids | 1 | 2014 | 13 | 0.110 |
Why?
| | Phase Transition | 1 | 2014 | 24 | 0.110 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.110 |
Why?
| | Injections, Intraocular | 1 | 2014 | 10 | 0.110 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 86 | 0.110 |
Why?
| | Circular Dichroism | 1 | 2014 | 149 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 118 | 0.110 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 186 | 0.110 |
Why?
| | PC12 Cells | 1 | 2013 | 40 | 0.110 |
Why?
| | Retina | 1 | 2016 | 298 | 0.110 |
Why?
| | Stem Cell Transplantation | 1 | 2015 | 176 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 996 | 0.110 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 184 | 0.110 |
Why?
| | Nerve Growth Factor | 1 | 2013 | 30 | 0.110 |
Why?
| | Lysine | 1 | 2016 | 294 | 0.110 |
Why?
| | Porosity | 1 | 2013 | 102 | 0.100 |
Why?
| | Trastuzumab | 1 | 2013 | 96 | 0.100 |
Why?
| | Polyesters | 1 | 2013 | 76 | 0.100 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 194 | 0.100 |
Why?
| | Endothelium, Corneal | 1 | 2013 | 16 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 374 | 0.100 |
Why?
| | Gram-Negative Bacteria | 1 | 2013 | 73 | 0.100 |
Why?
| | Surface Properties | 1 | 2013 | 413 | 0.100 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 570 | 0.100 |
Why?
| | Cell Movement | 1 | 2017 | 967 | 0.100 |
Why?
| | Immunoassay | 1 | 2013 | 115 | 0.100 |
Why?
| | Bevacizumab | 1 | 2013 | 138 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2017 | 4193 | 0.090 |
Why?
| | Oligopeptides | 1 | 2013 | 271 | 0.090 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 955 | 0.090 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 361 | 0.090 |
Why?
| | Bacteria | 1 | 2018 | 858 | 0.090 |
Why?
| | Male | 6 | 2025 | 67762 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1738 | 0.080 |
Why?
| | Ultrasonography | 1 | 2013 | 759 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2057 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2847 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.070 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 450 | 0.070 |
Why?
| | Escherichia coli | 1 | 2013 | 815 | 0.070 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5757 | 0.070 |
Why?
| | Humans | 6 | 2025 | 137585 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1991 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2020 | 844 | 0.060 |
Why?
| | Injections | 1 | 2025 | 183 | 0.060 |
Why?
| | Female | 5 | 2021 | 73304 | 0.050 |
Why?
| | Pregnancy | 3 | 2021 | 6763 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 248 | 0.050 |
Why?
| | Bivalvia | 1 | 2020 | 8 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 265 | 0.040 |
Why?
| | Spinal Cord | 1 | 2021 | 370 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 856 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 239 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1502 | 0.020 |
Why?
| | Transcription Factors | 1 | 2020 | 1719 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2668 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 10811 | 0.020 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|